The following industries match your search criteria:
Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
Results are sorted by relevance.
Click on heading titles to sort results by different field.
| Type |
Product title / description
|
Pub
|
Price |
Report
|
A comprehensive overview of licensing deals and strategies employed by the top 10 pharma companies during 2008-09, with intertwined case study analysis and an assessment of evolving trends observed in the global pharmaceutical licensing landscape.
Published By Datamonitor
|
24 Mar 2010 |
$15200
|
Report
|
An overview of key trends shaping the pharmaceutical industry today, as well as drivers and resistors that are set to play a central role in the future as companies look to increase sales and boost profitability.
Published By Datamonitor
|
17 Mar 2010 |
$11400
|
Report
|
Analysis of spinal cord injury epidemiology, unmet needs and pipeline treatments. Provides assessment of potential market value and analysis of opportunities and threats facing developers of SCI treatments based on interviews with key opinion leaders
Published By Datamonitor
|
05 Mar 2010 |
$3800
|
Report
|
An overview of M&A trends for the top 150 global pharmaceutical companies during 2008 and 2009 with discussion of the drivers of recent deals, plus case study analysis of key M&As.
Published By Datamonitor
|
17 Dec 2009 |
$11400
|
Report
|
This report assesses the current landscape of and future opportunities for therapeutic vaccines outside cancer, covering therapeutic vaccine approaches in cardiovascular and metabolic, CNS, autoimmune and infectious diseases.
Published By Datamonitor
|
17 Dec 2009 |
$3800
|
Report
|
Revenue and financial performance analysis of the 22 largest Big Pharma M&A events since 1995.
Published By Datamonitor
|
10 Dec 2009 |
$7600
|
Report
|
Analysis of the current and future antipsychotic market. Includes country-specific sales forecasts to 2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.
Published By Datamonitor
|
28 Oct 2009 |
$15200
|
Report
|
Analysis of the current and future antidepressant drug class market. Includes sales forecasts to 2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.
Published By Datamonitor
|
08 Oct 2009 |
$15200
|
Report
|
Analysis of the future potential of anticonvulsants market. Includes sales forecasts over 2009-2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK) of key marketed brands, generics, and pipeline agents.
Published By Datamonitor
|
08 Oct 2009 |
$15200
|
Report
|
Full analysis of the current and future hormonal contraceptives drug market, with country-specific forecasts to 2018 of marketed, generic, and key pipeline drugs in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).
Published By Datamonitor
|
02 Oct 2009 |
$15200
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.